JPS5899416A - アレルギ−反応抑制剤及びその製法 - Google Patents

アレルギ−反応抑制剤及びその製法

Info

Publication number: JPS5899416A
Authority: JP; Japan
Prior art keywords: ethyl alcohol; streptococcus; allergic reaction; soluble; insoluble
Prior art date: 1981-12-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

JP19815181A

Other languages

English (en)

Japanese (ja)

Other versions

JPS6317811B2 (cs

Inventor

Makoto Enomoto

榎本　真

Yoshio Ueno

上野　芳夫

Yosuke Kawasaki

川崎　洋介

Fusae Iida

飯田　芙佐枝

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Kyokuto Fatty-Acid Corp

Original Assignee

Kyokuto Fatty-Acid Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1981-12-09

Filing date

1981-12-09

Publication date

1983-06-13

1981-12-09 Application filed by Kyokuto Fatty-Acid Corp filed Critical Kyokuto Fatty-Acid Corp

1981-12-09 Priority to JP19815181A priority Critical patent/JPS5899416A/ja

1983-06-13 Publication of JPS5899416A publication Critical patent/JPS5899416A/ja

1988-04-15 Publication of JPS6317811B2 publication Critical patent/JPS6317811B2/ja

Status Granted legal-status Critical Current

Links

206010020751 Hypersensitivity Diseases 0.000 title claims abstract description 24
208000030961 allergic reaction Diseases 0.000 title claims abstract description 16
239000002683 reaction inhibitor Substances 0.000 title abstract 4
238000002360 preparation method Methods 0.000 title description 10
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 44
235000019441 ethanol Nutrition 0.000 claims abstract description 22
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 22
239000000126 substance Substances 0.000 claims abstract description 12
235000014655 lactic acid Nutrition 0.000 claims abstract description 10
239000004310 lactic acid Substances 0.000 claims abstract description 10
239000004480 active ingredient Substances 0.000 claims abstract description 7
238000004519 manufacturing process Methods 0.000 claims description 8
238000000926 separation method Methods 0.000 claims description 7
230000003834 intracellular effect Effects 0.000 claims description 6
208000026935 allergic disease Diseases 0.000 claims description 2
230000007815 allergy Effects 0.000 claims 1
241000194017 Streptococcus Species 0.000 abstract description 10
241000894006 Bacteria Species 0.000 abstract description 9
241000194035 Lactococcus lactis Species 0.000 abstract description 8
235000014897 Streptococcus lactis Nutrition 0.000 abstract description 8
201000010099 disease Diseases 0.000 abstract description 8
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
235000013336 milk Nutrition 0.000 abstract description 7
239000008267 milk Substances 0.000 abstract description 7
210000004080 milk Anatomy 0.000 abstract description 7
230000000172 allergic effect Effects 0.000 abstract description 6
208000010668 atopic eczema Diseases 0.000 abstract description 6
208000006673 asthma Diseases 0.000 abstract description 4
208000015181 infectious disease Diseases 0.000 abstract description 2
208000030603 inherited susceptibility to asthma Diseases 0.000 abstract description 2
239000006228 supernatant Substances 0.000 description 20
230000001580 bacterial effect Effects 0.000 description 12
238000000034 method Methods 0.000 description 11
239000002244 precipitate Substances 0.000 description 11
210000004027 cell Anatomy 0.000 description 9
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
241001465754 Metazoa Species 0.000 description 8
238000002474 experimental method Methods 0.000 description 8
239000000843 powder Substances 0.000 description 8
241000700198 Cavia Species 0.000 description 7
238000012360 testing method Methods 0.000 description 7
238000011282 treatment Methods 0.000 description 7
206010070834 Sensitisation Diseases 0.000 description 6
230000000968 intestinal effect Effects 0.000 description 6
102000004169 proteins and genes Human genes 0.000 description 6
108090000623 proteins and genes Proteins 0.000 description 6
230000008313 sensitization Effects 0.000 description 6
239000007788 liquid Substances 0.000 description 5
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
241000283973 Oryctolagus cuniculus Species 0.000 description 4
229940024171 alpha-amylase Drugs 0.000 description 4
230000034994 death Effects 0.000 description 4
239000012153 distilled water Substances 0.000 description 4
239000008103 glucose Substances 0.000 description 4
208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 3
239000004382 Amylase Substances 0.000 description 3
208000003455 anaphylaxis Diseases 0.000 description 3
238000010171 animal model Methods 0.000 description 3
238000005119 centrifugation Methods 0.000 description 3
238000000855 fermentation Methods 0.000 description 3
230000004151 fermentation Effects 0.000 description 3
210000000936 intestine Anatomy 0.000 description 3
230000000813 microbial effect Effects 0.000 description 3
244000005700 microbiome Species 0.000 description 3
239000000203 mixture Substances 0.000 description 3
239000000047 product Substances 0.000 description 3
230000035939 shock Effects 0.000 description 3
239000000243 solution Substances 0.000 description 3
239000010414 supernatant solution Substances 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
206010002198 Anaphylactic reaction Diseases 0.000 description 2
241000700199 Cavia porcellus Species 0.000 description 2
206010010904 Convulsion Diseases 0.000 description 2
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
208000004262 Food Hypersensitivity Diseases 0.000 description 2
229920001202 Inulin Polymers 0.000 description 2
241000194036 Lactococcus Species 0.000 description 2
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
102000004316 Oxidoreductases Human genes 0.000 description 2
108090000854 Oxidoreductases Proteins 0.000 description 2
229920002472 Starch Polymers 0.000 description 2
102000004139 alpha-Amylases Human genes 0.000 description 2
108090000637 alpha-Amylases Proteins 0.000 description 2
239000000427 antigen Substances 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
239000007900 aqueous suspension Substances 0.000 description 2
238000009395 breeding Methods 0.000 description 2
230000001488 breeding effect Effects 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
230000036461 convulsion Effects 0.000 description 2
238000000586 desensitisation Methods 0.000 description 2
238000000502 dialysis Methods 0.000 description 2
230000000694 effects Effects 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
235000020932 food allergy Nutrition 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
229940029339 inulin Drugs 0.000 description 2
230000000877 morphologic effect Effects 0.000 description 2
230000004899 motility Effects 0.000 description 2
230000003287 optical effect Effects 0.000 description 2
230000001766 physiological effect Effects 0.000 description 2
238000001556 precipitation Methods 0.000 description 2
230000002265 prevention Effects 0.000 description 2
238000011160 research Methods 0.000 description 2
210000002345 respiratory system Anatomy 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
235000021055 solid food Nutrition 0.000 description 2
239000008107 starch Substances 0.000 description 2
235000019698 starch Nutrition 0.000 description 2
235000000346 sugar Nutrition 0.000 description 2
150000008163 sugars Chemical class 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
206010027654 Allergic conditions Diseases 0.000 description 1
206010002199 Anaphylactic shock Diseases 0.000 description 1
244000063299 Bacillus subtilis Species 0.000 description 1
235000014469 Bacillus subtilis Nutrition 0.000 description 1
241001609213 Carassius carassius Species 0.000 description 1
102000016938 Catalase Human genes 0.000 description 1
108010053835 Catalase Proteins 0.000 description 1
241000252203 Clupea harengus Species 0.000 description 1
241001478240 Coccus Species 0.000 description 1
206010011703 Cyanosis Diseases 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
206010012438 Dermatitis atopic Diseases 0.000 description 1
208000019872 Drug Eruptions Diseases 0.000 description 1
206010016946 Food allergy Diseases 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
238000003794 Gram staining Methods 0.000 description 1
208000031361 Hiccup Diseases 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
241000186660 Lactobacillus Species 0.000 description 1
206010033799 Paralysis Diseases 0.000 description 1
206010039085 Rhinitis allergic Diseases 0.000 description 1
102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
241000405115 Zela Species 0.000 description 1
239000002253 acid Substances 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
201000010105 allergic rhinitis Diseases 0.000 description 1
201000008937 atopic dermatitis Diseases 0.000 description 1
244000052616 bacterial pathogen Species 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
230000037396 body weight Effects 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
210000003850 cellular structure Anatomy 0.000 description 1
208000029771 childhood onset asthma Diseases 0.000 description 1
238000005056 compaction Methods 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000012258 culturing Methods 0.000 description 1
230000009089 cytolysis Effects 0.000 description 1
239000003814 drug Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000945 filler Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000012530 fluid Substances 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
239000008187 granular material Substances 0.000 description 1
239000006458 gyp medium Substances 0.000 description 1
235000019514 herring Nutrition 0.000 description 1
230000009610 hypersensitivity Effects 0.000 description 1
230000008105 immune reaction Effects 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
230000016784 immunoglobulin production Effects 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
238000010255 intramuscular injection Methods 0.000 description 1
239000007927 intramuscular injection Substances 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
229940039696 lactobacillus Drugs 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
210000003141 lower extremity Anatomy 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
239000012528 membrane Substances 0.000 description 1
230000027939 micturition Effects 0.000 description 1
150000002772 monosaccharides Chemical class 0.000 description 1
239000006199 nebulizer Substances 0.000 description 1
231100000957 no side effect Toxicity 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
231100000572 poisoning Toxicity 0.000 description 1
230000000607 poisoning effect Effects 0.000 description 1
238000012545 processing Methods 0.000 description 1
238000010926 purge Methods 0.000 description 1
230000000384 rearing effect Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
230000029058 respiratory gaseous exchange Effects 0.000 description 1
239000000523 sample Substances 0.000 description 1
230000028327 secretion Effects 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
206010040560 shock Diseases 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
238000010186 staining Methods 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
239000000725 suspension Substances 0.000 description 1
239000008399 tap water Substances 0.000 description 1
235000020679 tap water Nutrition 0.000 description 1
239000013077 target material Substances 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
231100000820 toxicity test Toxicity 0.000 description 1
238000002525 ultrasonication Methods 0.000 description 1
229960005356 urokinase Drugs 0.000 description 1
238000005303 weighing Methods 0.000 description 1
230000037303 wrinkles Effects 0.000 description 1

Landscapes

Medicines Containing Material From Animals Or Micro-Organisms (AREA)

JP19815181A 1981-12-09 1981-12-09 アレルギ−反応抑制剤及びその製法 Granted JPS5899416A (ja)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
JP19815181A JPS5899416A (ja)	1981-12-09	1981-12-09	アレルギ−反応抑制剤及びその製法

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP19815181A JPS5899416A (ja)	1981-12-09	1981-12-09	アレルギ−反応抑制剤及びその製法

Publications (2)

Publication Number	Publication Date
JPS5899416A true JPS5899416A (ja)	1983-06-13
JPS6317811B2 JPS6317811B2 (cs)	1988-04-15

Family

ID=16386301

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP19815181A Granted JPS5899416A (ja)	1981-12-09	1981-12-09	アレルギ−反応抑制剤及びその製法

Country Status (1)

Country	Link
JP (1)	JPS5899416A (cs)

1981
- 1981-12-09 JP JP19815181A patent/JPS5899416A/ja active Granted

Also Published As

Publication number	Publication date
JPS6317811B2 (cs)	1988-04-15

Publication	Publication Date	Title
US4271147A (en)	1981-06-02	Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same
JP2911603B2 (ja)	1999-06-23	新規な弱毒化シュードモナス・エルギノーザ株
Wannamaker	1983	Streptococcal toxins
CN110452842B (zh)	2021-03-19	乳双歧杆菌nbk-W13及其应用
EP0220387B1 (de)	1990-09-19	Konjugatimpfstoffe gegen Infektionen durch gramnegative Bakterien, Verfahren zu deren Herstellung sowie Verwendung derselben
RU2262943C2 (ru)	2005-10-27	Сомногенная активность непатогенных молочно-кислых бактерий
JPH05201828A (ja)	1993-08-10	化粧料用乳酸菌製剤
US4349540A (en)	1982-09-14	Process for preparing vaccines based on antigenic ribosomal fractions
JP2000004830A (ja)	2000-01-11	免疫調節活性分解物およびその製造方法並びにそれを用いた食品
JPS61257930A (ja)	1986-11-15	感染防御剤
EP1002539B1 (en)	2004-08-11	Immunomodulator comprising bacterial cells or cell wall decomposition products thereof
Winkelstein et al.	1974	Phagocytosis: the normal process and its clinically significant abnormalities
JPS5899416A (ja)	1983-06-13	アレルギ−反応抑制剤及びその製法
JPS5946488B2 (ja)	1984-11-13	アレルギ−反応抑制剤
GB2077101A (en)	1981-12-16	Antiallergic composition containing streptococci
JPH03151853A (ja)	1991-06-28	抗体およびそれを有効成分とする整腸食品
HU227086B1 (en)	2010-06-28	Lactobacillus vaccine for treating prostata inflammatory and benign prostata hyperplasia
JPH0149246B2 (cs)	1989-10-24
Wherry	1927	Tissue Hydration and Its Relation to Susceptibility and Immunity: As Shown by Skin Tests in Asthma, Chronic Sinusitis and Other Infections
JPS62103026A (ja)	1987-05-13	Ｓｏｄ活性剤およびその製造法
HOSONO et al.	1991	Superoxide dismutase activity in the crude cell extract from Streptococcus salivarius subsp. thermophilus 3535
KR960014620B1 (ko)	1996-10-19	신규한 약독화 녹농균 및 그를 이용한 녹농균 감염 예방 백신
US2040794A (en)	1936-05-12	Common-cold antigen
JPS5946490B2 (ja)	1984-11-13	抗アレルギ−剤及びその製法
KR970001704B1 (ko)	1997-02-14	약독화 녹농균주 cfcpa 20215를 이용한 녹농균 감염 예방 백신